Endothelial Damage and Activation of the Coagulation Cascade during Radio Frequency Catheter Ablation;Endoteliální Poškození a Aktivace Koagulační Kaskády Během Radiofrekvenč ní Katérové Ablace

Vnitrni Lekarstvi

Volumn 50, Issue 4, 2004, Pages 305-311

  Bulava, Alan ^a   Slavi L ^a   Fiala, M ^a   Heinc, P ^a   Lubena L ^a   Lukl, J ^a   Krcova V ^a   Indrak K ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Catheter ablations; Coagulation system; Complications; Pulmonary Vein Isolation; Thrombus

Indexed keywords

ANTICOAGULANT AGENT; BIOLOGICAL MARKER; D DIMER; HEPARIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR; WARFARIN; BLOOD CLOTTING FACTOR;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING; CATHETER ABLATION; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; ENDOTHELIUM LESION; EVALUATION; FEMALE; HEART ARRHYTHMIA; HUMAN; MALE; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PULMONARY VEIN; RADIATION DOSE; THROMBOGENESIS; THROMBUS; UPREGULATION; BLOOD; FIBRINOLYSIS; HEART MUSCLE CONDUCTION SYSTEM; INJURY; MIDDLE AGED; PHYSIOLOGY; THROMBOCYTE ACTIVATION; THROMBOSIS; VASCULAR ENDOTHELIUM;

BLOOD COAGULATION; BLOOD COAGULATION FACTORS; CATHETER ABLATION; ENDOTHELIUM, VASCULAR; FEMALE; FIBRINOLYSIS; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED; PLATELET ACTIVATION; THROMBOSIS;

EID: 1942438109     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Anfinsen, O. G., Gjesdal, K., Aass, H. et al.: When should heparin preferably be administered during radiofrequency catheter ablation? PACE 2001; 24: 5-12
2. Anfinsen, O. G., Gjesdal, K., Brosstad, F. et al.: The activation of platelet function, coagulation, and fibrinolysis during radiofrequency catheter ablation in heparinized patients. J. Cardiovasc. Electrophysiol. 1999; 10: 503-512
3. Bauer, K. A., Weitz, J. L.: Laboratory markers of coagulation and fibrinolysis, 1197-1210. In: Colman, R. W. et al.: Hemostasis and Thrombosis: Basic Principle and Clinical Practice: Philadelphia, J. B. Lippincott Co., 1994
4. Blann, A.: von Willebrand factor and the endothelium in vascular disease. Br. J. Biomed. Sci. 1993; 50: 125-134
5. Boisclair, M. D., Philippou, H., Lane, D. A.: Thrombogenic mechanisms in the human: fresh insights obtained by immunodiagnostic studies of coagulation markers. Blood Coagul. Fibrinolysis 1993; 4: 1007-1021
6. Dorbala, S., Cohen, A. J., Hutchinson, L. A. et al.: Does radiofrequency ablation induce a prethrombotic state? Analysis of coagulation system activation and comparison to electrophysiologic study. J. Cardiovasc. Electrophysiol. 1998; 9: 1152-1160
7. Folsom, A. R.: Hemostatic risk factors for atherothrombotic disease: an epidemiologic view. Throm. Haem. 2001; 86: 366-373
8. Franks, J. J., Kirsch, R. E., Kao, B. et al.: Fibrinogen and fibrinogen related peptides in cancer, 57-88. In: Marlani, G.: Pathophysiology of Plasma Protein Metabolism: London: Macmillan, 1984
9. Fritschi, J., Christe, M., Lammle, B. et al.: Platelet aggregation, beta-thromboglobulin and platelet factor 4 in diabetes mellitus and in patients with vasculopathy. Throm. Haem. 1984; 52: 236-239
10. Goli, V. D., Prasad, R., Hamilton, K. et al.: Transesophageal echocardiographic evaluation for mural thrombus following radiofrequency catheter ablation of accessory pathways. PACE 1991; 14: 1992-1997
11. Huang, S. K.: Radio-frequency catheter ablation of cardiac arrhythmias: appraisal of an evolving therapeutic modality. Am. Heart J. 1989; 118: 1317-1323
12. Johansson, L., Jansson, J. H., Boman, K. et al.: Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a hrst stroke. Stroke 2000; 31: 26-32
13. Kaplan, K. L., Owen, J.: Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 1981; 57: 199-202
14. Kongsgaard, E., Foerster, A., Aass, H. et al.: Power and temperature guided radiofrequency catheter ablation of the right atrium in pigs. PACE 1994; 17: 1610-1620
15. Lip, G. Y., Blann, A.: von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovasc. Res. 1997; 34: 255-265
16. Mannucci, P. M.: von Willebrand factor: a marker of endothelial damage? Arterioscler. Thromb. Vasc. Biol. 1998; 18: 1359-1362
17. Manolis, A. S., Maounis, T., Vassilikos, V. et al.: Pretreatment with antithrombotic agents during radiofrequency catheter ablation: a randomized comparison of aspirin versus ticlopidine. J. Cardiovasc. Electrophysiol. 1998; 9: 1144-1151
18. Manolis, A. S., Melita-Manolis, H., Vassilikos, V. et al.: Thrombogenicity of radiofrequency lesions: results with serial D-dimer determinations. J. Am. Coll. Cardiol. 1996; 28: 1257-1261
19. Michelucci, A., Antonucci, E., Conti, A. A. et al.: Electrophysiologic procedures and activation of the hemostatic system. Am. Heart J. 1999; 138: 128-132
20. Nordt, T. K., Peter, K., Ruef, J. et al.: Plasminogen activator inhibitor type-I (PAI-1) and its role in cardiovascular disease. Throm. Haem. 1999; 82: Suppl. 8
21. Redlitz, A., Plow, E. F.: Receptors for plasminogen and t-PA: an update. Bail. Clin. Haematol. 1995; 8: 313-327
22. Ruggeri, Z. M.: Structure and function of von Willebrand factor. Throm. Haem. 1999; 82: 576-584
23. Tanno, K., Kobayashi, Y., Kurano, K. et al.: Histopathology of canine hearts subjected to catheter ablation using radiofrequency energy. Jap. Circ. J. 1994; 58: 123-135
24. Thakur, R. K., Klein, G. J., Yee, R. et al.: Complications of radiofrequency catheter ablation: a review. Can. J. Cardiol. 1994; 10: 835-839
25. van Mourik, J. A., Boertjes, R., Huisveld, L. A. et al.: von Willebrand factor propeptide in vascular disorders: A tool to distinguish between acute and chronic endothelial cell perturbation. Blood 1999; 94: 179-185
26. van Mourik, J. A., Romani, W.: Von Willebrand factor propeptide in vascular disorders. Throm. Haem. 2001: 86: 164-171
27. Wang, T. L., Lin, J. L., Hwang, J. J. et al.: The evolution of platelet aggregability in patients undergoing catheter ablation for supraventricular tachycardia with radiofrequency energy: the role of antiplatelet therapy. PACE 1995; 18: 1980-1990
28. Zhou, L., Keane, D., Reed, G. et al.: Thromboembolic complications of cardiac radiofrequency catheter ablation: a review of the reported incidence, pathogenesis and current research directions. J. Cardiovasc. Electrophysiol. 1999; 10: 611-620